Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nzube Ekpunobi has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CIRCULATING TUMOUR DNA IN AFRICA: A STRATEGIC ANALYSIS OF A MINIMALLY INVASIVE BIOMARKER FOR CANCER DETECTION AND MONITORING

    by Nzube F. Ekpunobi, Michael Kyere, Eddison I. Oghonyon, James O. Abimbola, Kingsley C. Agu

    Cancer diagnostic pathways in Africa face delays, uneven pathology access and limited molecular testing. Circulating tumour DNA (ctDNA) offers minimally invasive access to tumour-derived molecular information, but its value depends on the clinical question, assay performance and availability of subsequent care. This narrative review examines ctDNA biology, analytical platforms and clinical applications, then evaluates priorities for African implementation. Targeted literature checks for this revision covered clinical trials, professional recommendations, cancer surveillance sources, and African studies. Plasma genotyping has defined uses in advanced cancer, while negative results may require tissue testing. Molecular residual disease predicts recurrence, but evidence for treatment changes is tumour- and stage-specific. A methylation-based multi-cancer validation study reported 99.5% specificity but only 16.8% stage I sensitivity. Ghanaian breast-cancer research demonstrates genomic feasibility; a multicentre East African Burkitt lymphoma study provides stronger evidence of diagnostic accuracy and shorter turnaround time. Neither establishes effectiveness across all cancers or African health systems. Specimen handling, clonal haematopoiesis, assay costs, pathology access and access to appropriate treatment remain decisive constraints. Implementation should begin with defined indications, locally evaluated workflows and quality assurance. Prospective evaluation should measure clinical benefit, total pathway costs and equitable access before wider expansion.

  • Occurrence and Antibiotic Susceptibility of Escherichia coli from Door Handles in the Faculty of Pharmacy, Nnamdi Azikiwe University, Agulu

    by Ezinne Obidike, Chidozie Ibezim, Nzube Ekpunobi, Nwasoluchukwu Obidi, Malachy Ugwu

    Door handles are high-contact surfaces that can serve as reservoirs for pathogenic microorganisms, including Escherichia coli, a significant cause of community- and hospital-acquired infections. Increasing antibiotic resistance among E. coli strains poses a public health challenge, necessitating local surveillance. This study investigated the prevalence of E. coli contamination on door handles within the Faculty of Pharmacy, Nnamdi Azikiwe University, Agulu, and assessed the antibiotic susceptibility patterns of the isolates. A total of 100 swab samples were collected from door handles across offices, classrooms, hostels, laboratories, clinic, and other locations. Samples were cultured in nutrient broth, subcultured on MacConkey agar, and pure isolates identified using Gram staining, cultural characteristics and biochemical tests. Antibiotic susceptibility testing was performed using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar with 12 commonly used antibiotics. Data were analyzed using CLSI breakpoints and Multiple Antibiotic Resistance Index (MARI) was used to assess multidrug resistance. Seventeen E. coli isolates were recovered, with the highest prevalence from hostel door handles (59%). Antibiotic susceptibility testing revealed high resistance to β-lactams, including Ampicillin/Sulbactam (94%) and Piperacillin/Tazobactam (88%), as well as third- generation cephalosporins such as Cefotaxime (82%). Conversely, 100% susceptibility was observed for Gentamicin, Azithromycin, and Chloramphenicol, while Ofloxacin and Levofloxacin retained significant activity (88% susceptibility). Twelve isolates (71%) exhibited multidrug resistance, with MARI values >0.2, suggesting exposure to high antibiotic pressure. The findings highlight the role of fomites in harboring multidrug-resistant E. coli, underscoring the need for improved hygiene practices, routine surveillance, and rational antibiotic use within academic environments.

  • Open Access

    Prevalence of Multidrug-Resistant Escherichia coli O157:H7 from Live Bird Markets in Lagos, Nigeria

    by Sandra Okoye, Chidimma Chukwunwejim, Nzube Ekpunobi, Oluwabunmi Ajasa, Israel Ojuade, Nwasoluchukwu Obidi, Kingsley Agu

    Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.

  • Open Access

    Gut Microbiome Dynamics and Their Emerging Role in Breast and Colorectal Cancer: Implications for Diagnosis and Therapy

    by Chukwunwejim C. R., Nzube F. Ekpunobi, Eddison Igho Oghonyon, Nwasoluchukwu Obidi, Kingsley C. Agu

    The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatment-related toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy—particularly in breast and colorectal cancers.

  • Open Access

    Gut microbiome dynamics and their emerging role in breast and colorectal cancer: implications for diagnosis and therapy

    by Nzube Ekpunobi, Chidimma R Chukwunwejim, Sandra C Okoye, Eddison Igho Oghonyon, Nwasoluchukwu Obidi, Kingsley C Agu

    The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatmentrelated toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy-particularly in breast and colorectal cancers.


  • Open Access

    Prevalence and molecular detection of ESBL genes in uropathogens isolated from children and adolescents in a General Hospital in Lagos, Nigeria

    by N. F. Ekpunobi, M. C. Ugwu, K. C. Agu, C. R. Chukwunwejim, C. H. Nedum, L. C. Okoye, U. C. Mgbedo

    Background: Urinary tract infections (UTIs) are a significant global health concern with rising antimicrobial resistance (AMR) posing a serious challenge to effective treatment. The increasing prevalence of extendedspectrum beta-lactamase (ESBL)-producing uropathogens further complicates management, as these bacteria are resistant to third-generation cephalosporins and other β-lactam antibiotics. The objective of this study is to determine the prevalence and characterize ESBL genes in uropathogens isolated from children with UTIs in Ajeromi General Hospital, Ajegunle, Lagos, Nigeria.Methodology: A total of 165 children and adolescents presenting with symptoms of UTI were consecutively recruited into the study. Socio-demographic and clinical characteristics were collected from the participants using a structured data collection developed for the study. Voided midstream urine sample was collected from each participant. Standard microbiological methods were used to isolate and identify uropathogens from the sample, followed by antibiotic susceptibility testing (AST) using the Kirby-Bauer disk diffusion method. ESBL production was phenotypically detected by the double-disk synergy test (DDST), and conventional polymerase chain reaction (PCR) assay was performed to detect blaTEM and blaCTX-M1 ESBL genes.Results: Of the 165 children and adolescents whose urine samples were collected, 49 (26.7%) tested positive for significant bacterial growth, with Escherichia coli (53.1%) and Klebsiella pneumoniae (16.3%) being the predominant bacterial isolates. The AST revealed high resistance rates to third-generation cephalosporins (with 76.9% to ceftriaxone) and carbapenem (imipenem). While the phenotypic DDST did not confirm ESBL production in any of the isolates, PCR detected ESBL genes in 37 (75.5%) isolates.Conclusion: Our study highlights the widespread presence of ESBL-producing uropathogens, despite limitations in phenotypic detection methods, underscoring the need for routine molecular screening in AMR surveillance. The findings emphasize the critical role of antibiotic stewardship, infection control measures, empirical treatment guidelines, and promoting targeted molecular diagnostics in preventing the spread of multidrug-resistant (MDR) uropathogens.


  • Open Access

    Molecular identification of multidrug-resistant bacteria from eggshell surfaces in Nigeria: A growing threat to public health

    by Chidimma Ruth Chukwunwejim, Nzube Favour Ekpunobi, Temitope Ogunmola, Nwasoluchukwu Obidi, Oluwabunmi Seun Ajasa, Ngozi L Obidi

    Background: Eggs are an affordable dietary staple in Nigeria, yet they pose a potential public health risk when contaminated. This study assessed the prevalence of pathogenic bacteria and their antimicrobial resistance profiles on eggshells from markets in Lagos, Nigeria. Methods: A total of 51 table eggs were randomly sampled from poultry farms and supermarkets. Bacterial isolation and identification were conducted using standard microbiological methods, biochemical testing, and 16S rRNA gene sequencing. Antimicrobial susceptibility was evaluated using the Kirby-Bauer disc diffusion method. Results: All eggshell samples (100%) were contaminated with bacteria, with Staphylococcus aureus being the most prevalent organism. Other isolates included Escherichia coli, Bacillus cereus, and Salmonella typhimurium. Alarmingly, most isolates displayed complete resistance to first-line antibiotics like erythromycin and penicillin, while remaining susceptible to only gentamicin and ciprofloxacin. Conclusion: The widespread bacterial contamination and high levels of antimicrobial resistance observed on eggshells represent a significant public health threat. These findings underscore the urgent need for improved biosecurity in poultry production, enhanced hygiene in market environments, public education on food safety, and systematic surveillance under the One Health framework to mitigate risks associated with contaminated eggs.


  • Open Access

    Human-monkey interactions and zoonotic disease risk in an urban Nigerian community: A cross-sectional study

    by Nwasoluchukwu Obidi, Nzube Favour Ekpunobi, Chidimma Ruth Chukwunwejim, Eze Kenechukwu, Aniefuna C. Obiajulu, Ngozi Lilian Obidi, Temitope Ogunmola, Oluwabunmi Seun Ajasa, Onyeka Mirabelle

    Zoonotic diseases, transmitted between animals and humans, pose a growing threat to public health, particularly in regions where urbanization increases human-wildlife interactions. This study assessed public awareness and risk perception regarding zoonotic disease transmission between humans and monkeys in Awka, Anambra State, Nigeria—a region where such encounters are increasingly common. Using a cross-sectional design, data were collected via a structured online questionnaire administered to 448 residents representing diverse age groups, occupations, and education levels. Findings revealed that 89.1% of participants had encountered monkeys, mainly in residential areas, farms, and schools. Although 85.9% were aware of zoonotic diseases, knowledge was concentrated on high-profile infections such as monkeypox (72.9%) and Ebola (35.6%), with limited awareness of tuberculosis (11.9%) and HIV (3.4%). Most respondents correctly identified direct transmission routes such as contaminated food, contact with saliva or urine, and bites or scratches, but only 14.1% recognized airborne transmission. Risk perception was moderate, with 56.3% acknowledging a significant threat of zoonotic transmission. However, preventive behaviours were often limited to avoidance, and only 42.9% of those attacked by monkeys sought medical treatment. A majority (59.4%) expressed dissatisfaction with government and health authority interventions, although 75% showed willingness to participate in public health campaigns. This study underscores the need for intensified public health education and intersectoral collaboration to address zoonotic risks. Effective community-based interventions are essential to bridge knowledge gaps and promote proactive health-seeking behaviour in the face of increasing human-wildlife contact.


  • Open Access

    Antimicrobial Resistance in Pediatric UTIs: Molecular Profiles, Clinical Burden, and Public Health Implications of ESBL-Producing Uropathogens

    by Nzube Ekpunobi, Malachy Ugwu, Kingsley Agu, Chidimma Chukwunwejim, Eddison Oghonyon, Temitope Ogunmola, Oluwabunmi Ajasa, Sandra Okoye, Nwasoluchukwu Obidi

    Urinary tract infections (UTIs) remain a common and serious health challenge among pediatric populations, particularly in low- and middle-income countries. The emergence of extended-spectrum beta-lactamase (ESBL)-producing uropathogens significantly complicates treatment, increases the risk of complications, and burdens already fragile healthcare systems. This review provides a comprehensive analysis of the epidemiology, molecular mechanisms, clinical impact, and treatment challenges associated with ESBL-producing Enterobacteriaceae in pediatric UTIs, with a focused lens on Nigeria and the broader Sub-Saharan African region. We examine the predominance of Escherichia coli and Klebsiella pneumoniae as key ESBL producers, highlight the molecular dominance of CTX-M-15 and co-existing resistance determinants, and discuss the role of clonal expansion and horizontal gene transfer in the spread of resistance. Regional surveillance data reveal alarming ESBL prevalence rates of 40–75%, with multidrug resistance further narrowing treatment options. The implications are profound—ranging from delayed treatment and increased hospitalization to long-term renal complications in children. Despite the availability of phenotypic and molecular diagnostics, challenges persist due to limited access, infrastructural gaps, and under-resourced healthcare systems. This review underscores the urgent need for improved antimicrobial stewardship, investment in rapid diagnostics, and the establishment of pediatric-specific treatment guidelines. Addressing the burden of ESBL-producing uropathogens in Nigerian children is critical for safeguarding individual patient outcomes and mitigating the regional and global spread of antimicrobial resistance.


  • Open Access

    A narrative review exploring phage therapy as a sustainable alternative solution to combat antimicrobial resistance in Africa: Applications, challenges and future directions

    by N. O. Obidi, N. F. Ekpunobi

    The increasing threat of antimicrobial resistance (AMR) in Africa, coupled with limited access to advanced antibiotics and high rates of bacterial infections poses serious public health challenge. Bacteriophages, viruses that target and destroy bacteria, present a promising alternative or complementary therapy to traditional antibiotics. Phage therapy leverages its unique ability to target specific bacterial strains without affecting the host beneficial microbiota. It is an effective tool against multi-drug-resistant (MDR) microbial pathogens, particularly in resource-limited settings. This narrative review explores the potentials of phage therapy in Africa, highlighting its advantages, such as specificity, minimal side effects, and cost-effectiveness, alongside its capability to tackle biofilm-associated and AMR infections. It discusses current research and collaborations, including case studies from Nigeria, Benin, and South Africa that demonstrate the efficacy of phage therapy against bacterial pathogens such as Escherichia coli, Acinetobacter baumannii and Klebsiella pneumoniae. Furthermore, it discusses the challenges to phage therapy implementation such as regulatory hurdles, public skepticism, and infrastructure limitations, while emphasizing the importance of developing local production and awareness campaigns. The review concludes by recommending the integration of phage therapy into Africa healthcare strategies to address AMR. Through strategic partnerships, education and regulatory frameworks, phage therapy could become a transformative solution, particularly for neglected diseases and infections common in low-resource settings. As Africa seeks innovative approaches to its growing AMR crisis, phage therapy stands out as a viable and adaptable option.